𝔖 Bobbio Scriptorium
✦   LIBER   ✦

VP16-213and cyclophosphamide in advanced breast cancer

✍ Scribed by J. Estapé; L. Cirera; A. Millá; F. Doncel


Book ID
104685796
Publisher
Springer
Year
1983
Tongue
English
Weight
286 KB
Volume
10
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Doxorubicin, cyclophosphamide and VP16-2
✍ Joseph Aisner; Margaret Whitacre; David A. VanEcho; Margaret Wesley; Peter H. Wi 📂 Article 📅 1982 🏛 Springer 🌐 English ⚖ 742 KB

Small cell lung cancer requires aggressive combination chemotherapy. The three active agents, doxorubicin (A) 45 mg/m2 i.v. day 1, cyclophosphamide (C) 1.0 mg/m2 i.v. day 1 and VP16-213 (E) 50 mg/m2/day i.v. days 1-5 were given together. The combination (ACE) was given every 21 days without chest ir